FDA Clearance Tracker · P850009-S001
CA 125 ANTIBODY RIA
Last checked: Nov 20, 2026Latest source record: Jul 28, 1987 (this decision)Source: openFDAMethods & limitations
Decided
Jul 28, 1987
Approved
Time to decision
50 days
Received Jun 8, 1987. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P850009-S001
- Device name
- CA 125 ANTIBODY RIA
- Applicant
- Centocor, Inc.
- Applicant location
- Malvern, PA
- Received
- Jun 8, 1987
- Decided
- Jul 28, 1987
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Other
- Original approval
- P850009
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.6010
- Specialty
- Laboratory Medicine & Pathology
Source documents
Other decisions for Centocor, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.